| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025110 |
| Receipt No. | R000028872 |
| Official scientific title of the study | Development of the hepato-biliary-pancreatic tumor-specific imaging technique on targeting amino acid transporter |
| Date of disclosure of the study information | 2017/01/01 |
| Last modified on | 2018/02/01 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Development of the hepato-biliary-pancreatic tumor-specific imaging technique on targeting amino acid transporter | |
| Title of the study (Brief title) | Development of the novel tumor-specific imaging technique | |
| Region |
|
|
| Condition | ||
| Condition | hepatocellular carcinoma,biliary tract cancer,pancreatic cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To develop the novel imaging technique for hepato-biliary-pancreatic tumor |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Intratumoral accumulation and distribution of the PET probe ([18F]AA-7 and [18F]FDG) before and after treatment |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | [18F]AA-7 | |
| Interventions/Control_2 | [18F]FDG | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients
1) with hepato-biliary-pancreatic tumor in Osaka City University Hospital, who give informed consent. Diagnostic criteria Hepatocellular carcinoma: imaging (ultrasonography, CT, MRI, angiography), tumor marker (AFP, PIVKA-2), pathological diagnosis Biliary and pancreatic tumor: imaging (ultrasonography, CT, MRI, angiography, ERCP) , tumor marker (CEA, CA19-9, SPAN-1, DUPAN-2), pathological diagnosis 2) who is between 20 and 80 years old (regardless of sex) 3) who give informed consent 4) who can be hospitalized before examination for controlling blood sugar and amino acid levels 5) who can survive more than six months 6) who can reach the ECOG score 0 or 1 |
|||
| Key exclusion criteria | Patients
1) with serious brain and/or kidney disease 2) with a history of chemotherapy 3) with pregnancy women 4) with claustrophobia 5) with grade C of Child-Pugh score (Hepatocellular carcinoma) 6) who are judged as not suitable for participation in this study |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Norifumi Kawada |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Hepatology |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan |
| TEL | 06-6645-3905 |
| kawadanori@med.osaka-cu.ac.jp | |
| Public contact | |
| Name of contact person | Satoshi Nozaki |
| Organization | Osaka City University Graduate School of Medicine |
| Division name | Department of Physiology |
| Address | 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan |
| TEL | 06-6645-3711 |
| Homepage URL | |
| satoshi.nozaki@riken.jp | |
| Sponsor | |
| Institute | Osaka City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪市立大学医学部付属病院(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028872 |